Literature DB >> 19471925

Prognostic risk stratification of myocardial ischaemia evaluated by gated myocardial perfusion SPECT in patients with chronic kidney disease.

Tsuguru Hatta1, Shigeyuki Nishimura, Tsunehiko Nishimura.   

Abstract

PURPOSE: The aim of this study was to identify useful predictors of cardiac events in patients with chronic kidney disease (CKD).
METHODS: Among 4,031 patients identified from the Japanese Assessment of Cardiac Events and Survival Study (J-ACCESS) database with suspected or known ischaemic heart disease, we selected 820 with an estimated glomerular filtration rate (eGFR) of < 60 ml/min per 1.73 m(2).
RESULTS: A total of 75 cardiac events developed among these 820 patients. The incidence of cardiac events was higher in the group with a lower eGFR. Multivariate Cox analysis indicated that age, diabetes mellitus, end-systolic volume, summed stress score (SSS) and eGFR were predictors of cardiac events. Event rates of patients with SSS >or= 9 were significantly higher in groups with lower eGFR values (< 40 and 40-49 ml/min).
CONCLUSION: The SSS value (>or= 9) is a reliable predictor of cardiac events and myocardial single photon emission computed tomography has incremental value for predicting cardiac events and survival in CKD.

Entities:  

Mesh:

Year:  2009        PMID: 19471925     DOI: 10.1007/s00259-009-1165-2

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  16 in total

1.  The cardiorenal connection.

Authors:  Lennart G Bongartz; Maarten Jan M Cramer; Branko Braam
Journal:  Hypertension       Date:  2004-02-16       Impact factor: 10.190

Review 2.  Blood pressure control--special role of the kidneys and body fluids.

Authors:  A C Guyton
Journal:  Science       Date:  1991-06-28       Impact factor: 47.728

3.  Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction.

Authors:  R Hachamovitch; D S Berman; L J Shaw; H Kiat; I Cohen; J A Cabico; J Friedman; G A Diamond
Journal:  Circulation       Date:  1998-02-17       Impact factor: 29.690

4.  Prognostic value of dobutamine stress echocardiography in patients with chronic kidney disease.

Authors:  Sébastien Bergeron; Graham S Hillis; Eric N Haugen; Jae K Oh; Kent R Bailey; Patricia A Pellikka
Journal:  Am Heart J       Date:  2007-03       Impact factor: 4.749

5.  Surveillance study for creating the national clinical database related to ECG-gated myocardial perfusion SPECT of ischemic heart disease: J-ACCESS study design.

Authors:  Hideo Kusuoka; Shigeyuki Nishimura; Akira Yamashina; Kenichi Nakajima; Tsunehiko Nishimura
Journal:  Ann Nucl Med       Date:  2006-04       Impact factor: 2.668

6.  Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease.

Authors:  Donal N Reddan; Lynda Anne Szczech; Robert H Tuttle; Linda K Shaw; Robert H Jones; Steve J Schwab; Mark Stafford Smith; Robert M Califf; Daniel B Mark; William F Owen
Journal:  J Am Soc Nephrol       Date:  2003-09       Impact factor: 10.121

7.  Predictive value of myocardial perfusion single-photon emission computed tomography and the impact of renal function on cardiac death.

Authors:  Abdul Hakeem; Sabha Bhatti; Kathryn Sullivan Dillie; Jeffrey R Cook; Zainab Samad; Michelle D Roth-Cline; Su Min Chang
Journal:  Circulation       Date:  2008-12-01       Impact factor: 29.690

8.  Systolic dysfunction portends increased mortality among those waiting for renal transplant.

Authors:  Angelo M de Mattos; Andrew Siedlecki; Robert S Gaston; Gilbert J Perry; Bruce A Julian; Clifton E Kew; Mark H Deierhoi; Carlton Young; John J Curtis; Ami E Iskandrian
Journal:  J Am Soc Nephrol       Date:  2008-03-27       Impact factor: 10.121

9.  Prognostic value of stress myocardial perfusion imaging using adenosine triphosphate at the beginning of haemodialysis treatment in patients with end-stage renal disease.

Authors:  Hiroki Hase; Nobuhiko Joki; Hiroyasu Ishikawa; Hiroshi Fukuda; Yoshihiko Imamura; Tomokatsu Saijyo; Yuri Tanaka; Yasunori Takahashi; Yoji Inishi; Masato Nakamura; Masao Moroi
Journal:  Nephrol Dial Transplant       Date:  2004-02-19       Impact factor: 5.992

10.  Diagnostic accuracy and prognostic value of combined dipyridamole-exercise thallium imaging in hemodialysis patients.

Authors:  M Dahan; B M Viron; M Faraggi; D L Himbert; B J Lagallicier; A M Kolta; F Pessione; D Le Guludec; R Gourgon; F E Mignon
Journal:  Kidney Int       Date:  1998-07       Impact factor: 10.612

View more
  18 in total

Review 1.  Prognosis in the era of comparative effectiveness research: where is nuclear cardiology now and where should it be?

Authors:  Leslee J Shaw; Fadi G Hage; Daniel S Berman; Rory Hachamovitch; Ami Iskandrian
Journal:  J Nucl Cardiol       Date:  2012-10       Impact factor: 5.952

Review 2.  Non-invasive risk assessment in patients with chronic kidney disease.

Authors:  Abdul Hakeem; Sabha Bhatti; Alejandro R Trevino; Zainab Samad; Su Min Chang
Journal:  J Nucl Cardiol       Date:  2011-05       Impact factor: 5.952

3.  Ischemia and inflammation on chronic kidney disease.

Authors:  Nagara Tamaki
Journal:  J Nucl Cardiol       Date:  2017-07-27       Impact factor: 5.952

4.  Risk stratification based on J-ACCESS risk models with myocardial perfusion imaging: Risk versus outcomes of patients with chronic kidney disease.

Authors:  Kenichi Nakajima; Satoko Nakamura; Hiroki Hase; Yasuchika Takeishi; Shigeyuki Nishimura; Yuhei Kawano; Tsunehiko Nishimura
Journal:  J Nucl Cardiol       Date:  2018-06-12       Impact factor: 5.952

5.  Prognostic value of normal stress myocardial perfusion imaging and ventricular function in Japanese patients with chronic kidney disease: a study based on the J-ACCESS-3 database.

Authors:  Shinro Matsuo; Kenichi Nakajima; Yasuchika Takeishi; Tsunehiko Nishimura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-03-03       Impact factor: 9.236

6.  Incremental prognostic value of SPECT-MPI in chronic kidney disease: A reclassification analysis.

Authors:  Amjad M Ahmed; Waqas T Qureshi; Wesley T O'Neal; Fatima Khalid; Mouaz H Al-Mallah
Journal:  J Nucl Cardiol       Date:  2017-01-03       Impact factor: 5.952

7.  Prognostic value of left ventricular dyssynchrony evaluated by gated myocardial perfusion imaging in patients with chronic kidney disease and normal perfusion defect scores.

Authors:  Hiroaki Mori; Satoshi Isobe; Susumu Suzuki; Kazumasa Unno; Ryota Morimoto; Naoaki Kano; Takahiro Okumura; Yoshinari Yasuda; Katsuhiko Kato; Toyoaki Murohara
Journal:  J Nucl Cardiol       Date:  2017-04-21       Impact factor: 5.952

8.  Prognostic value of myocardial perfusion single photon emission computed tomography for major adverse cardiac cerebrovascular and renal events in patients with chronic kidney disease: results from first year of follow-up of the Gunma-CKD SPECT multicenter study.

Authors:  Shu Kasama; Takuji Toyama; Makito Sato; Hirokazu Sano; Tetsuya Ueda; Toyoshi Sasaki; Takehiro Nakahara; Tetsuya Higuchi; Yoshito Tsushima; Masahiko Kurabayashi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-09-25       Impact factor: 9.236

9.  Myocardial perfusion imaging for predicting cardiac events in Japanese patients with advanced chronic kidney disease: 1-year interim report of the J-ACCESS 3 investigation.

Authors:  Nobuhiko Joki; Hiroki Hase; Yuhei Kawano; Satoko Nakamura; Kenichi Nakajima; Tsuguru Hatta; Shigeyuki Nishimura; Masao Moroi; Susumu Nakagawa; Tokuo Kasai; Hideo Kusuoka; Yasuchika Takeishi; Mitsuru Momose; Kazuya Takehana; Mamoru Nanasato; Shunichi Yoda; Hidetaka Nishina; Naoya Matsumoto; Tsunehiko Nishimura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-05-15       Impact factor: 9.236

10.  Cardiac risk assessment by gated single-photon emission computed tomography in asymptomatic end-stage renal disease patients at the start of dialysis.

Authors:  Jwa-Kyung Kim; Sung Gyun Kim; Hyung Jik Kim; Young Rim Song
Journal:  J Nucl Cardiol       Date:  2011-12-28       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.